To further explore the anti-tumor growth effects of 4SC-202 in OS cells, we performed flow-cytometric quantification of an apoptotic response using annexin V and PI double staining on cells treated with the drug for 24 h. The gene discussed is ANXA5; the disease is neoplasm.